Salute e Benessere

Santhera's Shareholders Approve all Board Proposals at Today's Annual General…

Pratteln, Switzerland, June 18, 2024 – Santhera Pharmaceuticals (SIX: SANN) announces that its shareholders approved all motions by the Board of Directors at the Annual General Meeting (AGM) held today in Pratteln, Switzerland, with a large majority. Participating shareholders represented a total of 4,535,785 shares or 35.9% of the Company's share capital. Approval of the 2023 Annual Report and discharge of corporate bodiesThe shareholders approved the Annual Report, the annual...
Nasdaq GlobeNewswire
18/06/2024

Novo Nordisk announces presentation of data from key semaglutide clinical trials…

FLOW kidney outcomes trial data evaluating efficacy and safety of once-weekly semaglutide 1.0 mg in people with type 2 diabetes 1 SELECT cardiovascular outcomes trial data evaluating efficacy and safety of once-weekly semaglutide 2.4 mg in people with obesity and established cardiovascular disease, without diabetes 2 STEP HFpEF trial programme data evaluating efficacy and safety of once-weekly semaglutide 2.4 mg in people with obesity-related heart failure with preserved ejection...
Nasdaq GlobeNewswire
18/06/2024

Zero Candida Announces First Intellectual Property in South Africa

The company is in the process of applying to the TSX Venture Exchange inCanadato list its shares at a proposed valuation of40 million Canadian dollars. Zero-Candida's technology is a game changer that has the potential to change the treatment of women and FemTech industry in the world. The first of its kind technology uses a controlled "Blue Light" to destroy the fungus at record speed and without side effects. The treatment is carried out by a tampon-like medical device which,...
PR Newswire
18/06/2024

Sidekick Health Expands Oncology and Women's Health Portfolio with Acquisition…

This acquisition brings with it PINK! Coach, the only permanently listed prescription digital therapeutic (PDT) for breast cancer within Germany's regulated nationwide DiGA (Digitale Gesundheitsanwendungen) formulary. PINK! Coach is a digital application developed to enhance health-related quality of life and health literacy, while also addressing the psychological, psychosomatic, and physical effects of breast cancer. To achieve a lasting improvement in quality of life and health, PINK! Coach…
PR Newswire
18/06/2024

Ability Biologics Announces the Closing of its US $18 Million Seed Funding…

"We're seeing a need for a new generation of antibodies and modalities as simply binding, blocking or agonizing a single receptor is not enough to achieve therapeutic impact," said Giles Day, Co-founder and CEO of Ability. "At Ability, our platform overlays multiple approaches in a single molecule, enhancing specificity and selectivity to develop potent therapeutics with broad therapeutic windows. To do so, our antibodies employ tried and tested IgG formats that enable easier…
PR Newswire
18/06/2024

Calliditas provides setanaxib patent update

"We are delighted that the product protection of setanaxib in the area of oncology is extended by way of this patent, and we look forward to expanding this to other geographies", said Renee Aguiar-Lucander, CEO. "We are delighted that the product protection of setanaxib in the area of oncology is extended by way of this patent, and we look forward to expanding this to other geographies", saidRenee Aguiar-Lucander, CEO. Calliditas read out positive topline results of its Phase…
PR Newswire
18/06/2024

Pie Medical Imaging announces enrollment completion of the FASTIII clinical…

Following the tremendous efforts of the principal investigator, Dr Joost Daemen (cardiologist at Thoraxcenter at the Erasmus University Medical Center, Rotterdam, The Netherlands), over 35 participating centers and ECRI (sponsor of the trial), the patient enrollment has concluded. Following the tremendous efforts of the principal investigator,DrJoost Daemen (cardiologist at Thoraxcenter at theErasmus UniversityMedical Center,Rotterdam, The Netherlands ), over 35 participating...
PR Newswire
18/06/2024

Medical devices industry statistics & trends: A multi-billion dollar opportunity…

Horizon Databook is the largest market research database with over one million data points across 20,000+ markets. The platform is first-in-class and is designed to service a full suite of market research clients. It is a one, five solution platform and includes the following: Horizon Databook is the largest market research database with over one million data points across 20,000+ markets. The platform is first-in-class and is designed to service a full suite of market research…
PR Newswire
18/06/2024

Future Health Index 2024 global report: Healthcare leaders turn to AI to address…

Healthcare leaders indicate automation is crucial in addressing staff shortages, but staff remain skeptical Interest in Generative AI grows, with majority of health leaders investing in, or planning to invest in AI technologies to help reduce delays in patient care Amsterdam, the Netherlands– Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the results of its Future Health Index 2024 report:Better care for more people. Launched...
Nasdaq GlobeNewswire
18/06/2024

Nexstim Plc: Disclosure of Major Holdings according to Chapter 9, Section 10 of…

Company announcement, Helsinki, 18 June 2024 at 11:30 AM (EEST) Nexstim Plc: Disclosure of Major Holdings according to Chapter 9, Section 10 of the Finnish Securities Markets Act Nexstim Plc (NXTMH:HEX) (”Nexstim” or ”Company”) has received a notification pursuant to chapter 9, section 5 of the Securities Market Act from Ossi Haapaniemi on 17 June 2024.The notification is based on the amendment to the Securities Market Act effective April 19, 2024, requiring shareholders to notify the...
Nasdaq GlobeNewswire
18/06/2024

Basecamp Research launches ZymCTRL a world-first, open source, generative AI…

LONDON, June 18, 2024 /PRNewswire/ -- Basecamp Research, a world leader in artificial intelligence (AI)-based design of proteins and other biological systems, in partnership with the Ferruz Laboratory at the Institute of Molecular Biology of Barcelona today announced the release of ZymCTRL ("enzyme control"), a ChatGPT-like tool that generates new sequences from scratch based on a user simply typing in an enzyme identification code, which specifies the desired activity. LONDON,June 18…
PR Newswire
18/06/2024

Alvotech and Advanz Pharma Sign Commercialization Agreement for Proposed…

Advanz Pharma secures rights to commercialize Alvotech's biosimilar candidate for Eylea® in EuropeAdvanz Pharma will leverage its existing specialty and hospital capabilities in Europe to ensure successful market registration, commercialization, and patient access REYKJAVIK, ICELAND and LONDON, UK (June 18, 2024)— Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a UK...
Nasdaq GlobeNewswire
18/06/2024

Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the…

Lung cancer is currently the most prevalent malignant tumor with the highest mortality rate in China. Small cell lung cancer (SCLC) is the most aggressive subtype of lung cancer, accounting for approximately 15%-20% of all lung cancer cases with characteristics including rapid progression, early metastasis and poor prognosis. SCLC is divided into limited-stage small cell lung cancer (LS-SCLC) and ES-SCLC. For patients with LS-SCLC, an objective response rate of approximately 90% and a...
Nasdaq GlobeNewswire
18/06/2024

AMSilk attends Pitti Filati for the first time to showcase biofabricated premium…

"Pitti Filati is the place to be for innovative yarns, as it attracts the most prestigious and influential brands and designers from around the world. Italy is also a key destination for us, as it is known for its high degree of excellence in fashion and textiles." commented Benoit Cugnet, Head of Fiber BU, AMSilk. "Pitti Filati is the place to be for innovative yarns, as it attracts the most prestigious and influential brands and designers from around the world.Italyis also a…
PR Newswire
18/06/2024

SpyBiotech Appoints Keith Dewedoff as new Chief Financial Officer

"I am proud to join the SpyBiotech team as the company continues to expand," said Keith Dewedoff. "Given the recently announced research collaboration with the University of Oxford and SpyBiotech's Phase I trial of its HCMV vaccine, this is a really exciting time to join the company." "I am proud to join the SpyBiotech team as the company continues to expand," saidKeith Dewedoff. "Given the recently announced research collaboration with theUniversity of…
PR Newswire
18/06/2024

Bioretec Appoints Frank Sarcone as Vice President of Sales for the US and a…

Frank Sarcone brings with him a wealth of experience and a remarkable track record in the medical device sector. With over 25 years of experience, Sarcone is recognized for his exceptional leadership, strategic acumen, and ability to build and mentor high-performing teams. His extensive background includes founding and leading successful orthopedic companies and developing national distribution channels that have significantly boosted sales and market presence. Frank Sarconebrings with him a...
PR Newswire
18/06/2024

Invitation to presentation of Essity's interim report for quarter 2, 2024

Contact information for conference call with the possibility to ask questions:UK: +44 (0) 33 0551 02 00 USA: +1 786 697 35 01SWE: +46 (0)8 505 204 24Please call in well in advance of the start of the presentation. Indicate: "Essity". Contact information for conference call with the possibility to ask questions: UK: +44 (0) 33 0551 02 00 USA : +1 786 697 35 01 SWE: +46 (0)8 505 204 24 Please call in well in advance of the start of the presentation. Indicate…
PR Newswire
18/06/2024

TICA Secures Phase II Contract with Dubai HMS Mirdif Hospital

Mirdif Luxury Hospital, a premier medical institution in Dubai and the Middle East, known for its cutting-edge technology and premium services, is expanding through its Phase II project. The addition includes specialty wards and top-tier operating rooms. Prioritizing stringent environmental and air quality standards, the hospital conducted a thorough selection process for its equipment. TICA, recognized for its advanced technology and superior products, secured the contract, ensuring the…
PR Newswire
18/06/2024

ONWARD® Medical to Highlight Brain-Computer Interface at HLTH Europe Conference

CEO Dave Marver and trial participant Gert-Jan Oskam will discuss ONWARD ARC-BCI™ Therapy during main stage presentation CEO Dave Marver and trial participant Gert-Jan Oskam will address conference attendees in a keynote on the main stage on June 19, 2024. The pair will discuss how investigational ARC-BCI Therapy uses artificial intelligence to enable thought-driven movement after paralysis, the future of therapies to treat SCI, and Gert-Jan's experience as the first human to be implanted...
Nasdaq GlobeNewswire
18/06/2024

Santhera Secures up to CHF 69 million in Royalty and Debt Financing to Fund…

Ad hoc announcement pursuant to Art. 53 LR A conference call will be held on June 19, 2024, at 14:00 CEST / 13:00 BST / 08:00 EDT. Details are at the end of this news release. Funding underpins the advancement of AGAMREE® (vamorolone) roll-out and growth in Europe and the pursuit of further developmental initiatives Financing includes up to USD 38 million from R-Bridge, an affiliate of CBC Group, in exchange for a partial monetization of royalty payments received by Santhera in...
Nasdaq GlobeNewswire
18/06/2024

INCONTINENT? INTIMINA HAS A PLUMBER FOR THAT

During this time Stopcocks Women Plumbers will be fixing household leaks, having honest conversations about incontinence, and gifting customers INTIMINA's pelvic floor training device - KegelSmart 2. During this time Stopcocks Women Plumbers will be fixing household leaks, having honest conversations about incontinence, and gifting customers INTIMINA's pelvic floor training device - KegelSmart 2. Hattie Hasan MBE, Stopcocks Founder adds: " We deal with women's leaks daily, because our...
PR Newswire
18/06/2024

NMD Pharma Receives IND Clearance from the FDA to initiate a Phase 2 Clinical…

NMD Pharma Receives IND Clearance from the FDA to initiate a Phase 2 Clinical Trial of NMD670 in Charcot-Marie-Tooth disease in the USAarhus, Denmark, 18 June 2024– NMD Pharma A/S, a clinical-stage biotech company dedicated to developing novel and improved treatments for patients living with severe neuromuscular diseases, today announces that it has received clearance from the US Food and Drug Administration (FDA) for its Investigational New Drug (IND) application to initiate a Phase 2...
Nasdaq GlobeNewswire
18/06/2024

EUROAPI and Priothera enter into CDMO collaboration to advance oncology project

Press Release EUROAPI and Priothera, a biotechnology company specializing in the treatment of hematological malignancies and the improvement of CAR-T cell therapies, have signed a 5-year CDMO agreementEUROAPI will develop and industrialize the manufacturing process of innovative complex molecule for blood cancersParis – June 18, 2024– EUROAPI announces today the implementation of a 5-year development and manufacturing agreement with Priothera, a...
Nasdaq GlobeNewswire
18/06/2024

CARBIOS and TOMRA Textiles join forces to scale circularity of polyester…

CARBIOS and TOMRA Textiles will collaborate to close the textiles circularity gap between collection of textile waste and innovative technologies for textile-to-textile recyclingOslo/Clermont-Ferrand, Tuesday 18 June 2024 (6.45am CEST):CARBIOS (Euronext Growth Paris: ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, andTOMRA Textiles, a tech venture set up by sorting technology leaderTOMRA...
Nasdaq GlobeNewswire
18/06/2024
Altri  Comunicati